Merck KGaA Invests in Startup SynSense

By Kim Richters

Merck KGaA said Wednesday that it has invested in startup SynSense as part of an investors consortium.

The German pharmaceutical company said it invested via its China Seed Fund in a financing round led by CTC Capital. CAS Star, ECOVACS Robotics Co., Yunding, and Archer Investment also participated, it said.

Merck didn't comment on the financial terms of the investment in SynSense, which is a neuromorphic computing startup based in China and Switzerland.

"Our plan to be an active player in the China innovation landscape is paying off with this exciting step, which nicely complements our activities in our Performance Materials business sector," said Merck's Chief Strategy Officer Isabel de Paoli.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

May 06, 2020 04:13 ET (08:13 GMT)

Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024